Response To: "Study Results And Related Evidence Do Not Support Use Of Hpv16 L1 Drh1 Antibodies As A Cancer Screening Test"Thomas Weiland,Luka Brcic,Markus Reinholz,Lars E French,Dietmar ThurnherEBIOMEDICINE(2020)引用 1|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要